Age-related blood condition counteracted with a common diabetes drug

Common diabetes drug may 'slow down or prevent' cancer in those at risk of 'aggressive' form of disease - Manchester Evening News

A widely used diabetes drug holds promise in the treatment of the third biggest cancer killer in the UK, new research suggests

Age-related blood condition counteracted with a common diabetes drug

Metformin could reduce people’s risk of certain age-associated blood cancers, but more work is needed to identify who is likely to benefit. Metformin could reduce people’s risk of certain age-associated blood cancers, but more work is needed to identify who is likely to benefit.

Cheap Drug May Protect Millions From Deadly Cancer – Archyde

Archyde Common Diabetes Drug Metformin Shows Promise in Preventing Deadly Blood Cancer Cambridge University study suggests metformin, a widely used and inexpensive diabetes medication, may help prevent acute myeloid leukemia (AML) in individuals with a specific genetic mutation. U.S. clinical trials are anticipated to further validate these findings. April 16, 2025 Breakthrough Research on Metformin and […] You can read the full story here: Chea…